Aflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases

INTRODUCTION: In the western hemisphere, age-related macular degeneration (AMD) is the leading cause of visual loss in the elderly. Currently approved therapies for AMD include argon laser, photodynamic therapy, and antivascular endothelial growth factor (VEGF) therapy. The index review discusses af...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sophie, Raafay, Akhtar, Abeer, Sepah, Yasir J., Ibrahim, Mohamed, Bittencourt, Millena, Do, Diana V., Nguyen, Quan Dong
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Healthcare Communications 2012
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3873045/
https://ncbi.nlm.nih.gov/pubmed/24392297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13554-012-0003-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky